Endometriosis safety follow-up study in Ukraine

Princeton, NJ, USA, Nov 12, 2020

Global Clinical Trials launches new gynecology study in Ukraine. The project is sponsored by young EU biopharma company focused on research in women’s health.

It is a multicenter, open-label, single-arm Phase III study in 160 patients suffering from endometriosis. The study is designed to assess the safety and efficacy of the Investigational Product and will be conducted at up to 13 sites in Ukraine.

GCT team is providing the local support for the study including regulatory affairs, study and site management, clinical monitoring and logistics of IMP and clinical supplies.

“GCT team appreciates the trust of our partners and the repeat business they bring to us. At this time Ukraine is prepared for new studies more than ever with joint efforts of the regulatory authorities, healthcare professionals, and experts in the field,” – said Dr. Eugene Selivra, GCT CEO.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2020 Global Clinical Trials, LLC

All rights reserved.